BioSpace News Archive

BioMidwest

Maternal Monitoring Solution from AlertWatch Focuses on Maternal Safety During Labor & Delivery

AlertWatch, Inc., a leading provider of innovative clinical decision support software, announced the commercial launch of its maternal monitoring system, AlertWatch:OB.

January 7, 2020
·
2 min read
Business

Alzheon Announces Appointment of Peter N. Laivins as Head of Commercial Strategy and Planning

Industry veteran brings broad commercial expertise in neuroscience drug development and commercialization as Alzheon advances ALZ-801 into Phase 3 as potentially the first oral disease-modifying treatment for Alzheimer’s disease

January 7, 2020
·
5 min read
Pharm Country

Tonix Pharmaceuticals to Present at Biotech Showcase 2020

Tonix Pharmaceuticals Holding Corp. announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present and conduct investor meetings at Biotech Showcase 2020 being held January 13-15, 2020 at the Hilton San Francisco Union Square.

January 7, 2020
·
4 min read
Business

IRADIMED CORPORATION Announces Retirement of Brent Johnson and the Appointment of MaryBeth Smith as Vice President of Worldwide Sales

IRADIMED CORPORATION announced the retirement of Brent Johnson, Executive Vice President of Worldwide Sales and Marketing, effective April 10, 2020 after leading the Company’s commercial efforts since 2012.

January 7, 2020
·
5 min read
Bio NC

G1 Therapeutics to Present at 38th Annual J.P. Morgan Healthcare Conference

G1 Therapeutics, Inc., a clinical-stage oncology company, announced that Chief Executive Officer Mark Velleca, M.D., Ph.D. will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference.

January 7, 2020
·
1 min read
Business

IGM Biosciences Appoints Eric Humke, M.D., Ph.D., as Vice President, Clinical Development, Apoptosis

IGM Biosciences, Inc. announced the appointment of Eric Humke, M.D., Ph.D., to the newly created position of Vice President, Clinical Development, Apoptosis.

January 7, 2020
·
4 min read
Drug Development

Apellis Reports Positive Top-line Results from Phase 3 Head-to-Head Study of Pegcetacoplan (APL-2) Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Pegcetacoplan met the primary endpoint in the PEGASUS study, demonstrating superiority to eculizumab (p<0.0001) with an improvement in adjusted means of 3.8 g/dL of hemoglobin at week 16

January 7, 2020
·
9 min read
Pharm Country

Amicus Therapeutics Provides Updates on Clinical, Regulatory and Manufacturing Advancements for AT-GAA for Pompe Disease

Company Plans to Apply for and Initiate a Rolling Biologics License Application (BLA) for AT-GAA in 2020 with Addition of Full Clinical Results in 1H2021 to Support Full Approval under Fast Track Designation

January 7, 2020
·
7 min read
Drug Development

Synthetic Biologics Receives FDA Guidance at Type C Meeting for SYN-004 (ribaxamase) Phase 1b/2a Clinical Trial in Allogeneic HCT Recipients

Synthetic Biologics, Inc. announced the receipt of official meeting minutes from the U.S. Food and Drug Administration following a Type C meeting held on December 2, 2019 at the Company’s request to discuss the development of SYN-004 in allogeneic hematopoietic cell transplant recipients who are administered intravenous beta-lactam antibiotics in response to fever.

January 7, 2020
·
7 min read
Business

HSS-Trained Physician for Boston Bruins, Boston Red Sox and New England Patriots Appointed Medical Director of HSS Florida

New campus extends international ecosystem of world leader in orthopedics & rheumatology

January 7, 2020
·
4 min read